Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-18

Clinical Trial Update: Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial reporting relative bioavailability of pyronaridine-artesunate tablet versus granule formulations in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyronaridine-artesunate (pyronaridine/artesunate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2023-12-18